Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v2-FR Version v1-EN
Language French English
Date Updated 2025-07-30 2025-07-30
Drug Identification Number 02254689 02254689
Brand name FORTEO FORTEO
Common or Proper name teriparatide (rDNA origin) injection teriparatide (rDNA origin) injection
Company Name ELI LILLY CANADA INC ELI LILLY CANADA INC
Ingredients TERIPARATIDE TERIPARATIDE
Strength(s) 250MCG 250MCG
Dosage form(s) SOLUTION SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS SUBCUTANEOUS
Packaging size Carton package containing one 2.4 mL prefilled injection pen Carton package containing one 2.4 mL prefilled injection pen
ATC code H05AA H05AA
ATC description PARATHYROID HORMONES AND ANALOGUES PARATHYROID HORMONES AND ANALOGUES
Reason for discontinuation Business reasons Business reasons
Anticipated discontinuation date 2026-02-26 2026-02-26
Actual discontinuation date
Remaining supply date 2026-02-26 2026-02-26
Discontinuation status To be discontinued To be discontinued
Discontinuation decision reversal no no
Tier 3 Status No No
Information on remaining supply
Company comments For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays). For any questions, please contact our Customer Response Centre at 1-888-545-5972 (Monday-Friday, 9 a.m. to 5 p.m. Eastern Time, excluding holidays).
Health Canada comments